GS-441524
Product Specifications
Background
Parent nucleoside and active metabolite of the SARS-CoV2 drug remdesivir. Displayed broad spectrum antiviral activity against HCV, YFV, DENV-2, influenza A, parainfluenza 3, and SARS-CoV.1 It has been suggested that GS-441524 is superior as an anti-SARS-CoV2 drug due to simplicity of preparation compared to remdesivir, lack of on-target liver toxicity, and the fact that remdesivir is prematurely hydrolyzed to GS-441524 in human serum.2 Additionally, the enzymes that hydrolyze remdesivir to active metabolite GS-441524 are hardly expressed in lungs.
Conjugation
Unconjugated
Buffer
Off-white solid
Storage Conditions
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb3005738-01 20 µg
Recombinant Human Mitochondrial pyruvate carrier 1-like protein (MPC1L), partial, Biotinylated
Sign In for Pricing
View Details orb3005738-02 100 µg
Recombinant Human Mitochondrial pyruvate carrier 1-like protein (MPC1L), partial, Biotinylated
Sign In for Pricing
View Details orb3005738-03 1 mg
Recombinant Human Mitochondrial pyruvate carrier 1-like protein (MPC1L), partial, Biotinylated
Sign In for Pricing
View Details 
U4100-04B-ML490 100 µL
USP8, CT (Ubiquitin Carboxyl-terminal Hydrolase 8, Ubiquitin Thiolesterase 8, Ubiquitin-specific processing Protease 8, Deubiquitinating Enzyme 8, Ubiquitin Isopeptidase Y, hUBPy, KIAA0055, UBPY) (MaxLight 490) discontinued
Sign In for Pricing
View Details